| Literature DB >> 21251315 |
Ozlem Ates1, Ebru Toksoy Oner, Kazim Y Arga.
Abstract
BACKGROUND: Chromohalobacter salexigens (formerly Halomonas elongata DSM 3043) is a halophilic extremophile with a very broad salinity range and is used as a model organism to elucidate prokaryotic osmoadaptation due to its strong euryhaline phenotype.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21251315 PMCID: PMC3034673 DOI: 10.1186/1752-0509-5-12
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
Network characteristics of the reconstructed metabolic network of C. salexigens
| Protein-encoding gene models | 584 |
| Metabolites | 1411 |
| Intracellular metabolites | 920 |
| Extracellular metabolites | 491 |
| Reactions | 1386 |
| Enzymatic reactions | 876 |
| Transport fluxes | 510 |
| Reactions with protein-encoding gene model assignments | 886 |
| Enzymatic reactions | 856 |
| Transport fluxes | 30 |
Figure 1Characteristics of the reconstructed metabolic network . A: Distribution of the 12 main metabolic pathways in iOA584. B: Comparison of the distribution of enzyme classes in C. salexigens, E. coli and S. cerevisiae.
Figure 2Comparison of the reconstructed metabolic network with previous metabolic models from different domains. A: The distribution of reactions in C. salexigens, E. coli and S. cerevisae B: The distribution of reactions in C. salexigens,P. putida and P.aeruginosa
In silico predictions of the phenotypic features.
| (+/+) | Catalase (1.11.1.6) | rxn87 | |
| (+/+) | citrate synthase (2.3.3.1) | rxn328 | |
| (+/+) | Urease (3.5.1.5) | rxn610 | |
| (+/+) | Nitrate reductase (1.7.99.4) | rxn216-rxn218 | |
| (+/+) | rxn964 | rxn527, rxn559, rxn817 | |
| (-/-) | - | - | |
| (+/+) | rxn1112, rxn1113 | rxn136, rxn137, rxn243 | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (+/+) | rxn1004, rxn1005 | rxn83, rxn107, rxn580 | |
| (+/+) | rxn1007 | rxn328, rxn702, rxn726, rxn727 | |
| (-/-) | - | - | |
| (+/+) | rxn1079, rxn1080 | rxn62, rxn337, rxn433, rxn781 | |
| (+/+) | rxn1091 | rxn53 | |
| (+/+) | rxn877, rxn881, rxn882 | rxn82, rxn422 | |
| (+/+) | rxn1114 | rxn64 | |
| (-/-) | - | - | |
| (+/+) | rxn1173 | rxn33, rxn62 | |
| (+/+) | rxn1161 | rxn33, rxn781 | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (+/+) | rxn1274 | rxn418 | |
| (+/+) | rxn1284 | rxn17 | |
| (+/+) | rxn1312 | rxn729 | |
| (+/+) | rxn1327, rxn1328 | rxn562 | |
| (+/+) | rxn1101 | rxn53 | |
| (+/+) | rxn1385 | rxn22 | |
| (+/+) | rxn1060 | rxn427 | |
| (+/+) | rxn1065 | rxn2 | |
| (+/+) | rxn1081 | rxn155, rxn156, rxn158 - rxn162, rxn720, rxn753 - rxn755 | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (+/+) | rxn1109 | rxn763, rxn854 | |
| (+/+) | rxn1116 | rxn1, rxn429 | |
| (+/+) | rxn1118 | rxn182, rxn183, rxn257, rxn258, rxn605, rxn695, rxn802, rxn848, rxn859 | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (+/+) | rxn978 | rxn52 | |
| (+/+) | rxn979 | rxn275, rxn616, rxn661, rxn753, rxn807 | |
| (+/+) | rxn981 | rxn597 | |
| (-/-) | - | - | |
| (+/+) | rxn1103 | rxn175, rxn184, rxn389, rxn699, rxn806, rxn863, rxn868 - rxn872 | |
| (+/+) | rxn1153 | rxn104, rxn814 | |
| (-/-) | - | - | |
| (+/+) | rxn1209 | rxn267, rxn268, rxn750 | |
| (+/+) | rxn1248 | rxn195, rxn803 | |
| (-/-) | - | - | |
| (+/+) | rxn1290 | rxn37, rxn256, rxn257, rxn297, rxn298, rxn514 - rxn520, rxn721, rxn722, rxn751, rxn799, rxn800 | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (+/+) | rxn1155 | rxn46, rxn47, rxn84, rxn85, rxn720 | |
| (+/+) | rxn1156 | rxn122 | |
| (+/+) | rxn1157 | rxn587 | |
| (+/+) | rxn1170 | rxn96 | |
| (-/-) | - | - | |
| (+/+) | rxn1249 | rxn433 | |
| (-/-) | - | - | |
| (-/-) | - | - | |
| (+/+) | rxn1305 | rxn97, rxn98, rxn156, rxn159, rxn160, rxn163, rxn700, rxn841 | |
| (+/+) | rxn883, rxn884, rxn885 | rxn337 | |
| (+/+) | rxn1314 | rxn39, rxn439 | |
| (-/-) | - | - | |
Figure 3Experimental and in silico growth fluxes for batch cultivation of C.salexigens when glucose uptake rate was varying between 3.193 - 3.751 mmol/gDW/h
Figure 4. In C. salexigens, the osmoprotectant betaine is synthesized from its precursor choline in two steps. Whereas the first step from choline to betaine aldehyde is catalyzed either by membrane-bound choline dehydrogenase (EC 1.1.99.1, CsaI1514) or by a ferredoxin-dependent choline monooxygenase (EC 1.14.15.7, CsaI2455), betaine aldehyde dehydrogenase (EC 1.2.1.8, CsaI1515) is involved in the second, betaine aldehyde to betaine step. FBA simulations were performed with biomass as the objective function and 3 mmol/gDW/h glucose uptake rate and the computed metabolic flux values in mmol/gDW/h are shown on bar charts. Uptake of exogeneous choline was restricted to 0, 1.0, 1.2, 1.4, 1.6, 1.8 and 2 mmol/gDW/h.
Figure 5Ectoine biosynthesis pathway in C. Salexigens